Evidence map›Paper›PMID 31296657›Full record

ArticleThe Journal of biological chemistry2019

A cysteinyl-tRNA synthetase variant confers resistance against selenite toxicity and decreases selenocysteine misincorporation.

Kyle S Hoffman, Oscar Vargas-Rodriguez, Daniel W Bak, Takahito Mukai, Laura K Woodward, Eranthie Weerapana, Dieter Söll, Noah M Reynolds

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. An atlas of plant selenium metabolism.The New phytologist · 2026
    Review
  3. Catabolism of serine enantiomers represses enterohemorrhagicProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Review
  5. Article
  6. Scientific opinion on the tolerable upper intake level for selenium.EFSA journal. European Food Safety Authority · 2023
    Article
  7. Non-canonical Amino Acid Substrates of E. coli Aminoacyl-tRNA Synthetases.Chembiochem : a European journal of chemical biology · 2022
    Review
  8. Review
  9. Article
  10. Article
  11. HIF-1 Has a Central Role inFrontiers in genetics · 2020
    Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Kyle S HoffmanDepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, Connecticut 06511.ORCID 0000-0003-0170-2090
Oscar Vargas-RodriguezDepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, Connecticut 06511.ORCID 0000-0002-2301-2800
Daniel W BakDepartment of Chemistry, Boston College, Chestnut Hill, Massachusetts 02467.
Takahito MukaiDepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, Connecticut 06511.
Laura K WoodwardDepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, Connecticut 06511.
Eranthie WeerapanaDepartment of Chemistry, Boston College, Chestnut Hill, Massachusetts 02467.
Dieter SöllDepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, Connecticut 06511.ORCID 0000-0002-3077-8986
Noah M ReynoldsDepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, Connecticut 06511 nmreynol@uis.edu.ORCID 0000-0002-7591-6174
Yale University · USBoston College · US

Funding

Studies of Transfer RNAR35GM122560 · NIGMS · YALE UNIVERSITY · PI SOLL, DIETER · 2017 to 2022
$5.6M
Investigating cysteine-mediated protein activities in C. elegansR01GM118431 · NIGMS · BOSTON COLLEGE · PI WEERAPANA, ERANTHIE · 2015 to 2019
$1.8M
Investigating cysteine PTMs in living cellsR01GM117004 · NIGMS · BOSTON COLLEGE · PI WEERAPANA, ERANTHIE · 2016 to 2019
$1.2M
NIGMS NIH HHS R01 GM117004NIGMS NIH HHS R01 GM118431NIGMS NIH HHS R35 GM122560
6 · The paper itself

Abstract

Selenocysteine (Sec) is the 21st genetically encoded amino acid in organisms across all domains of life. Although structurally similar to cysteine (Cys), the Sec selenol group has unique properties that are attractive for protein engineering and biotechnology applications. Production of designer proteins with Sec (selenoproteins) at desired positions is now possible with engineered translation systems in

Indexed as

Amino Acyl-tRNA SynthetasesAstragalus PlantEscherichia coliGenetic Complementation TestHydrolysisSelenious AcidSelenocysteineAmino Acyl-tRNA Synthetasescysteinyl-tRNA synthetaseSelenious AcidSelenocysteineaminoacyl tRNA synthetaseAstragalus bisulcatuscysteinyl-tRNA synthetaseEscherichia coli (E. coli)protein engineeringselenite toxicityseleniumselenocysteinetransfer RNA (tRNA)translation

Identifiers

PMID31296657
PMCPMC6709638
OpenAlexW2959595486

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.